谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

HER2-low Expression Does Not Affect the Clinical Outcomes of Metastatic Breast Cancer Treated with CDK4/6 Inhibitor: A Real-World Study

Yingbo Shao,Zhifen Luo,Yang Yu,Qi Chen,Yaning He,Chaojun Liu,Bing Nie,Fangyuan Zhu,Hui Liu

Frontiers in Endocrinology（2022）

引用 6|浏览23
暂无评分
关键词
breast cancer,CDK4,6 inhibitor,HER2-low,endocrine therapy,palbociclib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要